Scarica l'app Stockscreener
4.90
0.41%
0.02
Dopo l'orario di chiusura:
4.90
Precedente Chiudi:
$4.88
Aprire:
$4.51
Volume 24 ore:
11,008
Relative Volume:
0.26
Capitalizzazione di mercato:
$7.29M
Reddito:
$59.11M
Utile/perdita netta:
$-33.38M
Rapporto P/E:
-0.0274
EPS:
-178.995
Flusso di cassa netto:
$-26.04M
1 W Prestazione:
+16.95%
1M Prestazione:
+34.99%
6M Prestazione:
-57.61%
1 anno Prestazione:
-80.83%
Intervallo 1D:
$4.51
$4.985
Intervallo di 1 settimana:
$4.25
$5.4499
Portata 52W:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Nome
Dna X Inc
Settore
Industria
Telefono
650-378-8100
Indirizzo
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.90 | 7.26M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corp
|
411.38 | 3.07T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
185.35 | 518.52B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
135.91 | 350.06B | 5.22B | 2.29B | 2.69B | 0.889 |
CRWD
Crowdstrike Holdings Inc
|
476.53 | 119.01B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
502.51 | 95.30B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-10-31 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Iniziato | B. Riley FBR | Buy |
| 2019-07-09 | Aggiornamento | National Securities | Neutral → Buy |
| 2019-06-10 | Iniziato | National Securities | Neutral |
| 2019-06-04 | Iniziato | Lake Street | Buy |
| 2019-06-04 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Dna X Inc Borsa (SONM) Ultime notizie
Central Bancompany, Inc. Announces Dividend Declaration and Reports May 2026 SEC Filing Results - Minichart
How DNA's Double Helix Structure Was Discovered - Britannica
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
[10-K/A] DNA X, Inc. Amends Annual Report - Stock Titan
[8-K] DNA X, Inc. Reports Material Event - Stock Titan
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference - 01net
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
SONM Price Today: DNA X, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today. - Cổng thông tin điện tử tỉnh Lào Cai
SONM (DNA X) tops Q3 2024 EPS forecasts, lifting shares nearly 10 percent on positive investor sentiment.Management Guidance - Cổng thông tin điện tử tỉnh Lào Cai
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - 富途牛牛
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
Global Experts Face-to-Face Interview Series – Redefining Yunnan’s Strategic Value - businessnewsthisweek.com
DNA X, Inc. Reports Full Year 2025 Financial Results - Scott Coop
DNA X sold its phone business for $15M to focus on crypto trading - Stock Titan
DNA X (NASDAQ: SONM) narrows 2025 loss and sells mobile unit to fund crypto pivot - Stock Titan
Earnings Report: Will Applied DNA Sciences Inc outperform its industry peersTrade Entry Report & Smart Allocation Stock Reports - baoquankhu1.vn
Tax-driven share sales follow PSU vesting at Ginkgo Bioworks (DNA) - Stock Titan
Restriction-enzyme DNA fingerprinting method explained - Britannica
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test - The Manila Times
DNA X : News Release - marketscreener.com
Non-controlling/minority interest of DNA X, Inc. – MUN:J6P - TradingView
Power DNA x Lain: Okori enerugî (Music Video 2017)News - IMDb
DNA X, Inc. delays 2025 annual filing - The Globe and Mail
Dna X Inc. Live Share Prices and Trades. SONM.US Live Streaming Share Prices. - London South East
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - Benzinga
[NT 10-K] DNA X, Inc. SEC Filing - Stock Titan
Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer - Business Wire
12 Information Technology Stocks Moving In Monday's Intraday SessionAmplitech Group, Inc.Series A R - Benzinga
Broadbent & Associates, Inc. receives Nevada Gold Mines ‘Results Driven’ DNA award - Northern Nevada Business Weekly
Feel Good Inc. X DNA. (Mashup) [1e740c] - Fathom Journal
DNA X (SONM) Surges 21.9% on Intraday Spike—What’s Behind the Volatility? - Bitget
The latest Star Wars Zero Company details tease Mass Effect DNA, hardcore turn-based tactics, permadeath, and new Clone Wars lore - Eurogamer.net
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
Dna Holdings Venture Inc. Net Worth (2026) - GuruFocus
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Equity in earnings of DNA X, Inc. – MUN:J6P - TradingView
Hitachi's DNA on Display at Its Birthplace Why the Company's Origin Park Matters as It Globalizes - 東洋経済オンライン
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - insidermonkey.com
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How do XX and XY Chromosomes Determine Biological Sex? - Britannica
Dna X Inc Azioni (SONM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):